Impact of COVID-19 Pandemic on Depression and Quality of Life

Sponsor
Okan University (Other)
Overall Status
Completed
CT.gov ID
NCT04394078
Collaborator
Yuksek Ihtisas University (Other)
543
1
12
1377.3

Study Details

Study Description

Brief Summary

It is aimed to investigate the depression and quality of life of Turkish society caused by Covid-19 pandemic and reveal the relationship between them

Condition or Disease Intervention/Treatment Phase
  • Other: Online survey

Detailed Description

Study hypothesis that people are tend to be depressed and the quality of life is affected negatively by Covid-19 pandemic. Although Turkey has affected moderately, the immediate change on depression and quality of life observable and measurable. It is aimed to investigate the depression and quality of life of Turkish society caused by Covid-19 pandemic and reveal the relationship between them. According to existing data and perspective of psychology and physiotherapy, potential solutions will be aligned.

Study Design

Study Type:
Observational
Actual Enrollment :
543 participants
Observational Model:
Ecologic or Community
Time Perspective:
Cross-Sectional
Official Title:
Impact of COVID-19 Pandemic on Depression and Quality of Life: Cross Sectional Study on Turkish Society and Suggestions on Potential Solution
Actual Study Start Date :
May 6, 2020
Actual Primary Completion Date :
May 18, 2020
Actual Study Completion Date :
May 18, 2020

Arms and Interventions

Arm Intervention/Treatment
Turkish society

Individuals speak Turkish and lives in Turkey, ages between 15 - 65, literate and with internet access

Other: Online survey
Volunteer individuals enrolled the study after approval an online informed consent form. Sociodemographic data of the participants recorded as an online survey. Then, patient reported outcomes were used to assess depression (Zung depression Scale) and quality of life (WHO Qualiy of Life - Bref version).

Outcome Measures

Primary Outcome Measures

  1. Sociodemographic information form [two months after Covid 19 recognised as pandemic]

    Participants are asked to give information about: age, gender, educational status, height, weight, occupation, working status, city inhabited, whether they live alone or with someone, whether they have a chronic disease, have a pet, do physical activity, eat healthy and sufficient, have qualified sleep, whether they are supported economically.

  2. Zung Depression Scale [two months after Covid 19 recognised as pandemic]

    Zung depression scale, developed by Zung (Zung, 1965), is patient rating depression scale, was used to asses four domains related to depression; somatic, mood disorders, psychomotor and psychological disorders. Each question is rated on a 4-point Likert scale (0- never, 1- sometimes, 2- frequently, 3- always). Scale contains 10 straight 10 reverse questions. The total score is calculated from the raw score obtained (total score = (raw score / 80) * 100). Accordingly, scores less than 50 are normal or no psychopathology; between 50 and 59 points indicates mild level, between 60 and 69 points indicate moderate level and 70 and above points indicate severe level depression (Thurber et al., 2002). The validity reliability of the scale was studied on Turkish society (Gencdogan & Nihal, 2011)

  3. World Health Organization Quality of Life - Bref [two months after Covid 19 recognised as pandemic]

    World Health Organization Quality of Life Bref is the short version of the WHOQOL-100 to assess the health-related quality of life (Harper et al., 1998), which has efficient psychometric properties, valid and reliable for Turkish society (Eser et al., 1999). It is essential for epidemiological survey and international report has built for psychometric properties for 26 country where Turkey within (Skevington et al., 2004). It has 4 domains; physical health, psychology, social relations and environment. Each question is answered on a 5-point Likert scale. The raw score is converted into a percentage system. The quality of life is interpreted as good as it gets closer to 100% (Akvardar et al., 2006).

Eligibility Criteria

Criteria

Ages Eligible for Study:
15 Years to 65 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • being Turkish

  • understanding Turkish

  • currently living in Turkey

  • being between the age of 15 - 65

  • being literate

  • have internet access

Exclusion Criteria:
  • being diagnosed with a psychological disorder before the pandemic

  • having missing value on outcome measures

  • giving incomprehensible answering

Contacts and Locations

Locations

Site City State Country Postal Code
1 Okan University Istanbul Turkey 34959

Sponsors and Collaborators

  • Okan University
  • Yuksek Ihtisas University

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Begüm Okudan, MSc. Pt, Okan University
ClinicalTrials.gov Identifier:
NCT04394078
Other Study ID Numbers:
  • 56665618-204.01.07
First Posted:
May 19, 2020
Last Update Posted:
Jun 11, 2020
Last Verified:
Jun 1, 2020
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Begüm Okudan, MSc. Pt, Okan University
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jun 11, 2020